FDA label a8a1829c-ac77-4a96-a873-0370b6b53da2

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
976a57b2-4bd8-4629-9b18-367f15dc91f2
SPL ID
a8a1829c-ac77-4a96-a873-0370b6b53da2
Version
4
Effective date
2014-08-20
Source export date
2026-10-12
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:47:33

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS BodyAnew Rejuveo: If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to BodyAnew Rejuveo™ or any of its ingredients exists. BodyAnew Purity: If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to BodyAnew Purity™ or any of its ingredients exists. BodyAnew Fatigue: If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. For occasional use only. Not a substitute for sleep. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to BodyAnew Fatigue™ or any of its ingredients exists.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.